XML 30 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ (3,316,495) $ 3,957,554
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 107,073 49,685
Change in fair value of contingent purchase consideration (1,936,164) (5,663,014)
Impairment of goodwill 932,203 0
Stock based compensation 627,678 834,929
Provision of bad debts and discounts 675,315 168,864
Provision for slow moving and obsolete inventory 2,093,858 601,129
Deferred income tax expense (benefit) 760,993 (431,272)
Changes in operating assets and liabilities:    
Accounts receivable (1,623,615) 917,689
Inventories, net of slow-moving and obsolescence reserves 1,126,144 1,280,427
Prepaid expenses and other current assets (10,297) 2,913
Accounts payable 39,935 (82,824)
Accrued expenses 518,633 843,820
Net cash provided by/(used in) operating activities (4,739) 2,479,900
Cash flows from investing activities:    
Purchases of property and equipment (15,318) (41,838)
Acquisition of Maxim Surgical, net of cash acquired   (63,097)
Net cash used in investing activities (15,318) (104,935)
Cash flows from financing activities:    
Net proceeds from senior secured revolving credit facility 275,053 (1,937,903)
Net cash provided by/(used in) financing activities 275,053 (2,335,366)
Net increase in cash and cash equivalents 254,996 39,599
Cash and cash equivalents - beginning of year 844,314 804,715
Cash and cash equivalents - end of year 1,099,310 844,314
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 94,545 107,521
Non-cash investing and financing activities:    
Inventory contributed by stockholder   2,063,742
CPM [Member]    
Cash flows from financing activities:    
Purchase price adjustment - CPM acquisition   (397,463)
Maxim Surgical, LLC [Member]    
Non-cash investing and financing activities:    
Stock issued for Maxim Acquisition   $ 3,281,757